Previous Close | 2.7400 |
Open | 2.7400 |
Bid | 2.7500 x 800 |
Ask | 2.8100 x 800 |
Day's Range | 2.6700 - 2.8100 |
52 Week Range | 0.5000 - 3.2200 |
Volume | |
Avg. Volume | 3,076,078 |
Market Cap | 416.411M |
Beta (5Y Monthly) | 1.68 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.8000 |
Earnings Date | May 09, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 7.00 |
Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that Craig Collard, Chief Executive Officer of Heron, will participate in a fireside chat on Wednesday, April 10, 2024, at 11:00 AM ET at the 23rd Annual Needham Virtual Healthcare Conference. The conference is being held in a virtual format, April 8-11, 2024.
Heron Therapeutics ( NASDAQ:HRTX ) Full Year 2023 Results Key Financial Results Revenue: US$127.0m (up 18% from FY...
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript March 12, 2024 Heron Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by, and welcome to the Heron Therapeutics Fourth Quarter 2023 Conference Call. I […]